儿童心脏骤停合并急性呼吸窘迫综合征中与死亡率相关的生物标志物
该研究为单中心前瞻性队列(2014-2019年)的二次分析,纳入333例儿童ARDS患者,其中301例单纯ARDS、32例ARDS合并心脏骤停(ARDS+CA),检测17种血浆生物标志物。ARDS+CA组的ARDS严重度、PRISM III评分、血管活性-正性肌力评分及肺外器官衰竭均更差;sRAGE、核小体、SP-D、CCL22、IL-6、HSP70、IL-8和MIP-1b在ARDS+CA组升高,校正病情严重度后sRAGE、SP-D和CCL22仍升高。在ARDS+CA亚组中,校正ARDS严重度和心脏骤停特征后,sRAGE、IL-6和颗粒酶B与死亡率相关;sRAGE在ARDS+CA组持续高于ARDS组并保留独立死亡关联。
要点
- ARDS+CA组(n=32)的sRAGE、IL-6和颗粒酶B在校正ARDS严重度及心脏骤停特征后与死亡率相关。
- sRAGE在ARDS+CA组持续高于单纯ARDS组(n=301),且校正病情严重度后仍与死亡率独立相关。
- ARDS+CA组69%的心脏骤停发生在院外,中位CPR持续时间为11分钟(IQR 5.5, 25)。
- 校正病情严重度后,sRAGE、SP-D和CCL22在ARDS+CA组仍高于单纯ARDS组。
- ARDS+CA组较单纯ARDS组的ARDS严重度、PRISM III评分、血管活性-正性肌力评分及肺外器官衰竭更差。
适用人群与场景
- 单中心前瞻性队列中2014-2019年收治的儿童ARDS患者,二次分析纳入333例,其中301例单纯ARDS、32例ARDS合并心脏骤停(ARDS+CA)。
研究设计与关键结果
- 研究类型为单中心前瞻性队列研究的二次分析,纳入333例儿童ARDS患者,检测17种血浆生物标志物。
- ARDS+CA组32例,中位年龄8岁,男性53.1%;单纯ARDS组301例,中位年龄5.3岁,男性55.5%。
- ARDS+CA组69%的心脏骤停发生在院外,中位CPR持续时间为11分钟(IQR 5.5, 25)。
- ARDS+CA组较单纯ARDS组的ARDS严重度、PRISM III评分、血管活性-正性肌力评分及肺外器官衰竭更差。
- ARDS+CA组较单纯ARDS组升高的生物标志物包括sRAGE、核小体、SP-D、CCL22、IL-6、HSP70、IL-8和MIP-1b。
- 按病情严重度匹配后,sRAGE、SP-D和CCL22在ARDS+CA组仍高于单纯ARDS组。
- 在ARDS+CA亚组中,校正ARDS严重度和心脏骤停特征后,sRAGE、IL-6和颗粒酶B与死亡率相关。
证据类型、等级与局限
- 证据类型:单中心前瞻性队列研究的二次分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,校正病情严重度后sRAGE、IL-6和颗粒酶B与儿童ARDS合并心脏骤停的死亡率相关,sRAGE在ARDS+CA组持续升高并保留独立死亡关联。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIMS: To identify plasma biomarkers associated with cardiac arrest in a cohort of children with acute respiratory distress syndrome (ARDS), and to assess the association of these biomarkers with mortality in children with cardiac arrest and ARDS (ARDS + CA).
METHODS: This was a secondary analysis of a single-center prospective cohort study of children with ARDS from 2014-2019 with 17 biomarkers measured. Clinical characteristics and biomarkers were compared between subjects with ARDS + CA and ARDS with univariate analysis. In a sub-cohort of ARDS + CA subjects, the association between biomarker levels and mortality was tested using univariate and bivariate logistic regression.
RESULTS: Biomarkers were measured in 333 subjects: 301 with ARDS (median age 5.3 years, 55.5% male) and 32 ARDS + CA (median age 8 years, 53.1% male). More arrests (69%) occurred out-of-hospital with a median CPR duration of 11 (IQR 5.5, 25) minutes. ARDS severity, PRISM III score, vasoactive-ionotropic score and extrapulmonary organ failures were worse in the ARDS + CA versus ARDS group. Eight biomarkers were elevated in the ARDS + CA versus ARDS cohort: sRAGE, nucleosomes, SP-D, CCL22, IL-6, HSP70, IL-8, and MIP-1b. sRAGE, SP-D, and CCL22 remained elevated when the cohorts were matched for illness severity. When controlling for severity of ARDS and cardiac arrest characteristics, sRAGE, IL-6 and granzyme B were associated with mortality in the ARDS + CA group.
CONCLUSION: sRAGE, IL-6 and granzyme B were associated with cardiac arrest mortality when controlling for illness severity. sRAGE was consistently higher in the ARDS + CA cohort compared to ARDS and retained independent association with mortality.
参考来源
- Gardner MM, Kirschen MP, Wong HR, et al. Biomarkers associated with mortality in pediatric patients with cardiac arrest and acute respiratory distress syndrome. Resuscitation. 2021. PMID: 34871756. doi:10.1016/j.resuscitation.2021.11.036
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。